Ireland mRNA Vaccines and RNAi Therapeutics Market (2025-2031) | Forecast, Companies, Outlook, Industry, Share, Trends, Segmentation, Analysis, Competitive Landscape, Size & Revenue, Value, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Ireland Country Macro Economic Indicators

3.2 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 Ireland mRNA Vaccines and RNAi Therapeutics Market - Industry Life Cycle

3.4 Ireland mRNA Vaccines and RNAi Therapeutics Market - Porter's Five Forces

3.5 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.6 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By Administration, 2021 & 2031F

3.7 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing research and development activities in the field of mRNA vaccines and RNAi therapeutics in Ireland

4.2.2 Growing demand for personalized medicine and targeted therapies

4.2.3 Rising prevalence of chronic diseases driving the need for innovative treatment options

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of mRNA vaccines and RNAi therapeutics

4.3.2 High costs associated with research, development, and production of these advanced therapies

4.3.3 Limited awareness and understanding among healthcare professionals and patients about the benefits of mRNA vaccines and RNAi therapeutics

6.1 Ireland mRNA Vaccines and RNAi Therapeutics Market, By Disease Type

6.1.1 Overview and Analysis

6.1.2 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Disease Type, 2021- 2031F

6.1.3 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Hereditary transthyretin-mediated amyloidosis genetic, 2021- 2031F

6.1.4 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Acute hepatic porphyria, 2021- 2031F

6.1.5 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Primary hyperoxaluria type 1, 2021- 2031F

6.1.6 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Atherosclerotic cardiovascular disease, 2021- 2031F

6.2 Ireland mRNA Vaccines and RNAi Therapeutics Market, By Administration

6.2.1 Overview and Analysis

6.2.2 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By IV infusion, 2021- 2031F

6.2.3 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3 Ireland mRNA Vaccines and RNAi Therapeutics Market, By End user

6.3.1 Overview and Analysis

6.3.2 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Research Institutes, 2021- 2031F

6.3.3 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F

7.1 Ireland mRNA Vaccines and RNAi Therapeutics Market Export to Major Countries

7.2 Ireland mRNA Vaccines and RNAi Therapeutics Market Imports from Major Countries

8.1 Research funding allocated to mRNA vaccines and RNAi therapeutics in Ireland

8.2 Number of clinical trials conducted for mRNA vaccines and RNAi therapeutics in the country

8.3 Adoption rate of mRNA vaccines and RNAi therapeutics by healthcare providers in Ireland

9.1 Ireland mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.2 Ireland mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By Administration, 2021 & 2031F

9.3 Ireland mRNA Vaccines and RNAi Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F

10.1 Ireland mRNA Vaccines and RNAi Therapeutics Market Revenue Share, By Companies, 2024

10.2 Ireland mRNA Vaccines and RNAi Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters